Navicixizumab

• Catalog Number: orb2703343
• Category: Antibodies
• Description: Navicixizumab (OMP-305B83) is a bispecific anti-VEGF and anti-DLL4 inhibitory antibody. Navicixizumab can combine with Paclitaxel.html" class="link-product" target="_blank"> Paclitaxel (HY-B0015) for cancer research. Navicixizumab can be used in the research of ovarian, primary peritoneal, or fallopian tube cancer.
• Target: Navicixizumab
• Conjugation: Unconjugated
• Antibody Type: Primary Antibody
• CAS Number: [1638338-43-8]
• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Note: For research use only